Kestra Medical Technologies, Ltd. (KMTS) Gross margin 2024–2026
Kestra Medical Technologies, Ltd. (KMTS) gross margin by fiscal year — reported gross profit divided by reported revenue.
51.4%FY2026 · since FY2024: 1.3% → 51.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | 51.4% | +10.9 pp |
| FY2025 | 40.5% | +39.2 pp |
| FY2024 | 1.3% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More KMTS financial trends
KMTS RevenueKMTS Net incomeKMTS Net marginKMTS Gross profitKMTS Operating incomeKMTS Operating marginKMTS Operating cash flowKMTS Free cash flowKMTS Capital expendituresKMTS Return on equityKMTS Stock buybacksKMTS Dividends paidKMTS Total assetsKMTS Total liabilitiesKMTS Shareholders’ equityKMTS overview →